Showing results (1261-1270 of 6,881) with videos related to
Sort By:
Pageof 689
Leukemia Research|May 4, 2012
Clinical significance of minimal residual disease detected by multidimensional flow cytometry: serial monitoring after allogeneic stem cell transplantation for acute leukemiaTakuya Miyazaki, Hiroyuki Fujita, Katsumichi Fujimaki, et al.Leukemia Research|December 11, 2012
Imatinib and Nilotinib inhibit Bcr-Abl-induced ROS through targeted degradation of the NADPH oxidase subunit p22phoxWilliam D Landry, John F Woolley, Thomas G CotterLeukemia Research|January 1, 2013
Phase II pilot study of oral dasatinib in patients with higher-risk myelodysplastic syndrome (MDS) who failed conventional therapyVu H Duong, Michael V Jaglal, Ling Zhang, et al.Leukemia Research|August 13, 2013
A role of NF-E2 in chronic inflammation and clonal evolution in essential thrombocythemia, polycythemia vera and myelofibrosis?Hans C HasselbalchLeukemia Research|August 14, 2013
Absolute monocyte count trichotomizes chronic lymphocytic leukemia into high risk patients with immune dysregulation, disease progression and poor survivalYair Herishanu, Sigi Kay, Nadav Sarid, et al.Leukemia Research|August 14, 2013
A comparative study of deferasirox and deferiprone in the treatment of iron overload in patients with myelodysplastic syndromesJaroslav Cermak, Anna Jonasova, Jana Vondrakova, et al.Leukemia Research|September 24, 2013
Prevalence of extramedullary relapses is higher after allogeneic stem cell transplantation than after chemotherapy in adult patients with acute myeloid leukemiaHiroaki Shimizu, Takayuki Saitoh, Nahoko Hatsumi, et al.Leukemia Research|September 24, 2013
CEBPA single mutation can be a possible favorable prognostic indicator in NPM1 and FLT3-ITD wild-type acute myeloid leukemia patients with intermediate cytogenetic riskSang Hyuk Park, Hyun-Sook Chi, Young-Uk Cho, et al.Leukemia Research|September 24, 2013
Increased expression of phosphorylated NBS1, a key molecule of the DNA damage response machinery, is an adverse prognostic factor in patients with de novo myelodysplastic syndromesMaria Kefala, Sotirios G Papageorgiou, Christos K Kontos, et al.Leukemia Research|September 3, 2013
Patients with polycythemia vera and essential thrombocythemia with prior malignancy do not have significantly worse outcomeMohamad Cherry, Marylou Cardenas-Turanzas, Hannah Pham, et al.Pageof 689